Cart
sales@molnova.com
PCNA-I1
CAS No. 444930-42-1
PCNA-I1( —— )
Catalog No. M24405 CAS No. 444930-42-1
PCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | In Stock |
|
| 10MG | 335 | In Stock |
|
| 25MG | 566 | In Stock |
|
| 50MG | 806 | In Stock |
|
| 100MG | 1098 | In Stock |
|
| 500MG | 2205 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePCNA-I1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
-
DescriptionPCNA-I1 is an inhibitor targeting PCNA chromatin association in prostate cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPCNA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number444930-42-1
-
Formula Weight310.37
-
Molecular FormulaC17H14N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1=C(SC=C1)C(=O)N/N=C/C2=C(C3=CC=CC=C3C=C2)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dillehay K L , Lu S , Dong Z . Antitumor Effects of a Novel Small Molecule Targeting PCNA Chromatin Association in Prostate Cancer[J]. Molecular Cancer Therapeutics, 2014, 13(12):2817-26.
molnova catalog
related products
-
BMS-986251
BMS-986251 is a Clinically Viable, Potent, and Selective RORγt Inverse Agonist.
-
BC-1471
STAMBP-IN-1 is a small-molecule inhibitor of STAMBP deubiquitinase, and interrupts STAMBP-Ub-NALP7 interaction. STAMBP-IN-1 decreases protein level of its inflammasome substrate NALP7 and suppresses IL-1b release after Toll-like receptor (TLR) agonism. STAMBP-IN-1 inhibits the activity of STAMBP to cleave recombinant di-Ub with an IC50 value of 0.33 mM
-
Limocitrin 3-O-sopho...
Limocitrin 3-O-sophoroside is a compound that can be used in biological research.
